scispace - formally typeset
D

Danny R. Youlden

Researcher at Cancer Council Queensland

Publications -  101
Citations -  5411

Danny R. Youlden is an academic researcher from Cancer Council Queensland. The author has contributed to research in topics: Population & Cancer. The author has an hindex of 30, co-authored 95 publications receiving 4667 citations. Previous affiliations of Danny R. Youlden include University of Queensland & Griffith University.

Papers
More filters
Journal ArticleDOI

The International Epidemiology of Lung Cancer Geographical Distribution and Secular Trends

TL;DR: Given the increasing incidence of lung cancer in less developed countries and the current lack of effective treatment for advanced lung cancers, these results highlight the need for ongoing global tobacco reform to reduce the international burden of Lung cancer.
Journal ArticleDOI

The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality

TL;DR: The future worldwide breast cancer burden will be strongly influenced by large predicted rises in incidence throughout parts of Asia due to an increasingly "westernised" lifestyle.
Journal ArticleDOI

The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics.

TL;DR: Lung cancer will continue to be a major health problem well through the first half of this century and preventive strategies, particularly tobacco control, tailored to populations at highest risk are key to reducing the global burden of lung cancer.
Journal ArticleDOI

International epidemiology of prostate cancer: geographical distribution and secular trends.

TL;DR: Current international patterns in prostate cancer incidence and mortality rates and survival are outlined, including recent trends and a discussion of the possible impact of prostate-specific antigen (PSA) testing on the observed data.
Journal ArticleDOI

Incidence and mortality of female breast cancer in the Asia-Pacific region.

TL;DR: It is anticipated that incidence rates of breast cancer in developing countries throughout the Asia-Pacific region will continue to increase, and the challenge is to customise breast cancer control initiatives to the particular needs of each country to ensure the best possible outcomes.